Lonza

Global CDMO delivering commercial development and manufacturing services for biologics, small molecule APIs, cell and gene therapies, and capsules.

Lonza

Lonza

CDMO & Manufacturing Featured

Biologics, Small Molecules & Cell/Gene Therapy Contract Manufacturing

Basel, Switzerland

Company Overview

Lonza is a preferred global partner to the pharmaceutical, biotech, and consumer health markets, enabling innovators to bring therapies to patients through advanced contract development and manufacturing.

Their technical capabilities cover commercial cGMP drug substance synthesis, mammalian cell culture, microbial fermentation, advanced bioconjugates, mRNA, and specialized particle engineering.

Lonza operates state-of-the-art manufacturing facilities across North America, Europe, and Asia, maintaining multi-agency regulatory compliance and comprehensive QA systems.